47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
64.92.Z - Other forms of credit granting
70 - Head office activities and management consultancy
73 - Advertising, market research and public relations
77 - Rental and leasing
82 - Office administrative support activities and other business support services
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,2 | 0,7 | 1 | 28,6 |
EBITDA | 1,3 | 0,8 | 1,1 | 25,5 |
Short time liabilities | 5,8 | 6,6 | 6,9 | 5,4 |
Equity capital | -1 | -1,2 | -0,6 | 53,2 |
Operating profit (EBIT) | 1,2 | 0,8 | 1 | 27,5 |
Assets | 5,2 | 5,5 | 6,5 | 18,3 |
Net profit (loss) | 1,2 | 0,7 | 1 | 28,6 |
Cash | 0,1 | 0,1 | 0,1 | 6,7 |
Net income from sale | 30 | 35,8 | 39,6 | 10,6 |
Liabilities and provisions for liabilities | 6,1 | 6,7 | 7 | 5,4 |
Working assets | 4,6 | 4,9 | 5,9 | 20,3 |
Depreciation | 0,1 | 0 | 0 | -10,6 |
% | % | % | p.p. | |
Profitability of capital | -122,5 | -61,8 | -169,7 | -107,9 |
Equity capital to total assets | -19,1 | -22,1 | -8,7 | 13,4 |
Gross profit margin | 4 | 2,1 | 2,4 | 0,3 |
EBITDA Margin | 4,3 | 2,3 | 2,7 | 0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 71 | 67 | 64 | -3 |
Current financial liquidity indicator | 0.7776132822036743 | 0.742542564868927 | 0.8476371169090271 | 0,1 |
Net dept to EBITDA | 0.6805770397186279 | 0.5447089076042175 | 0.16109342873096466 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane